Key Takeaways:
A.S. Watson Group, the retail unit of CKH Holdings (00001.HK), may pursue a dual listing in Hong Kong and London by the end of 2026 to raise about $2 billion.
"The group's business model balances stability and flexibility amid geopolitical uncertainties," Malina Ngai, CEO of A.S. Watson, said, without directly responding to the potential IPO plan.
The potential offering values the health and beauty giant at $30 billion, the Financial Times reported, citing people with knowledge of the matter. The company has reportedly been working with Goldman Sachs, UBS, and Latham & Watkins on the IPO, but has not yet selected a primary listing destination.
The move would mark one of Hong Kong's most significant listings in years, testing investor appetite for major retail operations.
The potential $2 billion fundraising provides a significant test for the Hong Kong and London IPO markets. First-day trading, should the listing proceed, will gauge global investor confidence in large-scale consumer retail amid a complex geopolitical landscape.
This article is for informational purposes only and does not constitute investment advice.
